![]() |
|
|
,**
* Department of Clinical Laboratory and Clinical Immunology, Medical University, Sofia, Bulgaria;
Lung Biology, Department of Health and
** Department of Life Sciences, Kings College London, UK; and
Department of Clinical Biochemistry, GKT School of Medicine, Kings College, Denmark Hill Campus, London, UK
3To whom correspondence should be addressed. E-mail: robert.simpson{at}kcl.ac.uk.
Ascorbate has long been thought to play an important role in intestinal iron absorption. The recent identification of a possible ascorbate-dependent duodenal ferric reductase suggests a role for intracellular ascorbate in the control of iron absorption. We set out to determine whether duodenal ascorbate concentrations are altered by treatments known to alter the rate of iron absorption and whether ascorbate levels affect duodenal reductase activity. Duodenal ascorbate was extracted and assayed by HPLC and/or a chemical assay. Ferric reductase was assayed in vitro with ferric nitrilotriacetate or nitroblue tetrazolium as substrates. Duodenal ascorbate concentrations were increased by iron deficiency, genetic hypotransferrinemia, and hypoxia. Parenteral iron overload increased iron stores but did not affect duodenal ascorbate concentrations. Hemolytic anemia induced in mice by phenylhydrazine injection also did not affect duodenal ascorbate concentrations. In vitro studies with incubated duodenum showed that decreased tissue ascorbate was associated with decreased mucosal ferric reductase activity, whereas incubation with dehydroascorbate prevented both the decrease in ascorbate concentration and reductase activity. Mouse duodenum ascorbate concentrations changed in response to treatments that altered iron absorption rates; in particular, ascorbate levels generally increased when iron absorption was increased by iron deficiency, hypoxia, or genetic hypotransferrinemia. We conclude that changes in ascorbate levels are associated with changes in ferric reductase activity. These findings are consistent with the proposal that duodenal ascorbate plays a role in intestinal iron absorption.
KEY WORDS: iron absorption ferric reductase iron overload iron deficiency hypotransferrinemia
This article has been cited by other articles:
![]() |
G. O. Latunde-Dada, R. J. Simpson, and A. T. McKie Duodenal Cytochrome B Expression Stimulates Iron Uptake by Human Intestinal Epithelial Cells J. Nutr., June 1, 2008; 138(6): 991 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gunshin, C. N. Starr, C. DiRenzo, M. D. Fleming, J. Jin, E. L. Greer, V. M. Sellers, S. M. Galica, and N. C. Andrews Cybrd1 (duodenal cytochrome b) is not necessary for dietary iron absorption in mice Blood, October 15, 2005; 106(8): 2879 - 2883. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Collins, C. A. Franck, K. V. Kowdley, and F. K. Ghishan Identification of differentially expressed genes in response to dietary iron deprivation in rat duodenum Am J Physiol Gastrointest Liver Physiol, May 1, 2005; 288(5): G964 - G971. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D Atanasova, A. C. Li, I. Bjarnason, K. N Tzatchev, and R. J Simpson Duodenal ascorbate and ferric reductase in human iron deficiency Am. J. Clinical Nutrition, January 1, 2005; 81(1): 130 - 133. [Abstract] [Full Text] [PDF] |
||||